Hollsteen
← Intuit

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: $1.1B · 10-Q 0000896878-15-000140 filed Nov 20, 2015Equity incl. NCI · Q2 FY2016: $641M · 10-Q 0000896878-16-000197 filed Feb 25, 2016Equity incl. NCI · Q3 FY2016: $1.2B · 10-Q 0000896878-16-000225 filed May 24, 2016Equity incl. NCI · Q4 FY2016: $1.5B · 10-K 0000896878-19-000132 filed Aug 30, 2019Equity incl. NCI · Q1 FY2017: $936M · 10-Q 0000896878-16-000316 filed Nov 18, 2016Equity incl. NCI · Q2 FY2017: $785M · 10-Q 0000896878-17-000030 filed Feb 23, 2017Equity incl. NCI · Q3 FY2017: $1.7B · 10-Q 0000896878-17-000048 filed May 23, 2017Equity incl. NCI · Q4 FY2017: $1.7B · 10-K 0000896878-19-000132 filed Aug 30, 2019Equity incl. NCI · Q1 FY2018: $1.6B · 10-Q 0000896878-18-000212 filed Nov 20, 2018Equity incl. NCI · Q2 FY2018: $1.7B · 10-Q 0000896878-19-000042 filed Feb 22, 2019Equity incl. NCI · Q3 FY2018: $2.9B · 10-Q 0000896878-19-000077 filed May 23, 2019Equity incl. NCI · Q4 FY2018: $2.8B · 10-K 0000896878-19-000132 filed Aug 30, 2019Equity incl. NCI · Q1 FY2019: $2.8B · 10-Q 0000896878-18-000212 filed Nov 20, 2018Equity incl. NCI · Q2 FY2019: $2.8B · 10-Q 0000896878-19-000042 filed Feb 22, 2019Equity incl. NCI · Q3 FY2019: $4.1B · 10-Q 0000896878-19-000077 filed May 23, 2019Equity incl. NCI · Q4 FY2019: $3.7B · 10-K 0000896878-19-000132 filed Aug 30, 2019Equity incl. NCI · Q1 FY2020: $3.6B · 10-Q 0000896878-19-000174 filed Nov 21, 2019Equity incl. NCI · Q2 FY2020: $3.7B · 10-Q 0000896878-20-000027 filed Feb 24, 2020Equity incl. NCI · Q3 FY2020: $4.7B · 10-Q 0000896878-20-000065 filed May 21, 2020Equity incl. NCI · Q4 FY2020: $5.1B · 10-K 0000896878-20-000148 filed Aug 31, 2020Equity incl. NCI · Q1 FY2021: $5.2B · 10-Q 0000896878-20-000223 filed Nov 19, 2020Equity incl. NCI · Q2 FY2021: $8.9B · 10-Q 0000896878-21-000059 filed Feb 23, 2021Equity incl. NCI · Q3 FY2021: $10.0B · 10-Q 0000896878-21-000115 filed May 25, 2021Equity incl. NCI · Q4 FY2021: $9.9B · 10-K 0000896878-21-000233 filed Sep 8, 2021Equity incl. NCI · Q1 FY2022: $9.7B · 10-Q 0000896878-21-000260 filed Nov 18, 2021Equity incl. NCI · Q2 FY2022: $15.6B · 10-Q 0000896878-22-000010 filed Mar 2, 2022Equity incl. NCI · Q3 FY2022: $17.0B · 10-Q 0000896878-22-000021 filed May 24, 2022Equity incl. NCI · Q4 FY2022: $16.4B · 10-K 0000896878-22-000028 filed Sep 2, 2022Equity incl. NCI · Q1 FY2023: $16.1B · 10-Q 0000896878-22-000036 filed Nov 29, 2022Equity incl. NCI · Q2 FY2023: $15.8B · 10-Q 0000896878-23-000010 filed Feb 23, 2023Equity incl. NCI · Q3 FY2023: $17.6B · 10-Q 0000896878-23-000020 filed May 23, 2023Equity incl. NCI · Q4 FY2023: $17.3B · 10-K 0000896878-23-000034 filed Sep 1, 2023Equity incl. NCI · Q1 FY2024: $17.0B · 10-Q 0000896878-23-000041 filed Nov 28, 2023Equity incl. NCI · Q2 FY2024: $16.9B · 10-Q 0000896878-24-000011 filed Feb 22, 2024Equity incl. NCI · Q3 FY2024: $18.8B · 10-Q 0000896878-24-000026 filed May 23, 2024Equity incl. NCI · Q4 FY2024: $18.4B · 10-K 0000896878-24-000039 filed Sep 4, 2024Equity incl. NCI · Q1 FY2025: $18.1B · 10-Q 0000896878-24-000053 filed Nov 21, 2024Equity incl. NCI · Q2 FY2025: $17.9B · 10-Q 0000896878-25-000015 filed Feb 25, 2025Equity incl. NCI · Q3 FY2025: $20.1B · 10-Q 0000896878-25-000022 filed May 22, 2025Equity incl. NCI · Q4 FY2025: $19.7B · 10-K 0000896878-25-000035 filed Sep 3, 2025Equity incl. NCI · Q1 FY2026: $19.3B · 10-Q 0000896878-25-000048 filed Nov 20, 2025Equity incl. NCI · Q2 FY2026: $19.1B · 10-Q 0000896878-26-000014 filed Feb 26, 2026Equity incl. NCI · Q3 FY2026: $20.6B · 10-Q 0000896878-26-000025 filed May 20, 2026Equity incl. NCI · Q4 FY2026: $19.0B · 10-K 0000896878-26-000037 filed Sep 9, 202616.419.01.120.6Q1 FY2016Q4 FY2026Q4 FY2022
$BEquity incl. NCI · Q4 FY2021: $9.9B · 10-K 0000896878-21-000233 filed Sep 8, 2021Equity incl. NCI · Q1 FY2022: $9.7B · 10-Q 0000896878-21-000260 filed Nov 18, 2021Equity incl. NCI · Q2 FY2022: $15.6B · 10-Q 0000896878-22-000010 filed Mar 2, 2022Equity incl. NCI · Q3 FY2022: $17.0B · 10-Q 0000896878-22-000021 filed May 24, 2022Equity incl. NCI · Q4 FY2022: $16.4B · 10-K 0000896878-22-000028 filed Sep 2, 2022Equity incl. NCI · Q1 FY2023: $16.1B · 10-Q 0000896878-22-000036 filed Nov 29, 2022Equity incl. NCI · Q2 FY2023: $15.8B · 10-Q 0000896878-23-000010 filed Feb 23, 2023Equity incl. NCI · Q3 FY2023: $17.6B · 10-Q 0000896878-23-000020 filed May 23, 202316.417.69.9Q4 FY2021Q3 FY2023Q4 FY2022
Q4 FY2022
16.4$B
All values (44)
PeriodValue ($B)Status
Q4 FY202619.0reported
Q3 FY202620.6reported
Q2 FY202619.1reported
Q1 FY202619.3reported
Q4 FY202519.7reported
Q3 FY202520.1reported
Q2 FY202517.9reported
Q1 FY202518.1reported
Q4 FY202418.4reported
Q3 FY202418.8reported
Q2 FY202416.9reported
Q1 FY202417.0reported
Q4 FY202317.3reported
Q3 FY202317.6reported
Q2 FY202315.8reported
Q1 FY202316.1reported
Q4 FY202216.4reported
Q3 FY202217.0reported
Q2 FY202215.6reported
Q1 FY20229.7reported
Q4 FY20219.9reported
Q3 FY202110.0reported
Q2 FY20218.9reported
Q1 FY20215.2reported
Q4 FY20205.1reported
Q3 FY20204.7reported
Q2 FY20203.7reported
Q1 FY20203.6reported
Q4 FY20193.7reported
Q3 FY20194.1reported
Q2 FY20192.8reported
Q1 FY20192.8reported
Q4 FY20182.8reported
Q3 FY20182.9reported
Q2 FY20181.7reported
Q1 FY20181.6reported
Q4 FY20171.7reported
Q3 FY20171.7reported
Q2 FY20170.8reported
Q1 FY20170.9reported
Q4 FY20161.5reported
Q3 FY20161.2reported
Q2 FY20160.6reported
Q1 FY20161.1reported

CSV with all sources · Technical ID: equity_total

More metrics for Intuit

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$16.4B
Period
Q4 FY2022, ended Jul 31, 2022 · as of Jul 31, 2022 (balance as of date, not a sum)
Source
10-K, filed Sep 2, 2022 · 0000896878-22-000028
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$16.4BSep 2, 202210-K 0000896878-22-000028reported · confidence 1. · current